CTRI/2023/04/052031尚未招募3 期
Double blind randomized placebo control study of lansoprazole for the treatment of functional dyspepsia in children
Fourrts pharmaceutical company0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •FUNCTIONAL DYSPEPSIA (Roams 4 criteria) -
- •Must include one or more of the following bothersome symptoms at least 4 times a month for at least 2 months prior to diagnosis:
- •Postprandial fullness
- •Early satiation
- •Epigastric pain or burning not associated with defecation
- •After appropriate evaluation, the symptoms cannot be fully explained by another medical condition
- •Within FD(Functional dyspepsia) the following subtypes are now adopted:
- •H2a1.  Postprandial distress syndrome includes bothersome postprandial fullness or early satiation which prevents finishing a regular meal. Supportive features include upper abdominal bloating, postprandial nausea, or excessive belching.
- •H2a2.  Epigastric pain syndrome which includes all of the following: bothersome (severe enough to interfere with normal activities) pain or burning localized to the epigastrium. The pain is not generalized or localized to other abdominal or chest regions and is not relieved by defecation or passage of flatus. Supportive criteria can include (a) burning quality of the pain but without a retrosternal component, (b) commonly induced or relieved by ingestion of a meal but may occur while fasting.
排除标准
- •1.Patient already on treatment with Proton pump inhibitors (PPI) /H2RA, Prokinetics ,NSAIDS or within 1 week of study commencement
- •2.Previous Gastrointestinal surgery and diseases (e.g. â?? ulcerative colitis, crohnâ??s disease)
- •3.Chronic systemic illness (liver,heart,renal diseases)
- •4.History of H. Pylori infection and treatment in last 6 months
研究者
相似试验
已完成
3 期
A clinical trial to study the effects of Homeopathic drug EMTACT in patients with Recurrent Upper and Lower Respiratory Tract affections.CTRI/2014/06/004673Homeopathy India Private Limited148
招募中
3 期
Assessment of efficacy of lithium in prevention of peripheral neuropathyChemotherapy induce peripheral neuropathy.IRCT20160813029327N10Islamic Azad University44
尚未招募
3 期
Comparing the use of oral misoprostol with vaginal misoprostol to facilitate spontaneous labourCTRI/2019/01/017318Fluid Research Grant
进行中（未招募）
不适用
A randomized placebo-controlled double blind study to treat BOS.-Mortality at 1 and 2 year post diagnosis of BOS-Infection rate during BOS-Evolution of pulmonary function after diagnosis of BOSMedDRA version: 12.1Level: LLTClassification code 10029888Term: Obliterative bronchiolitisMedDRA version: 12.1Level: LLTClassification code 10049202Term: Bronchiolitis obliteransMedDRA version: 12.1Level: LLTClassification code 10068805Term: Follicular bronchiolitisMedDRA version: 12.1Level: LLTClassification code 10019319Term: Heart-lung transplant rejectionMedDRA version: 12.1Level: LLTClassification code 10025127Term: Lung transplantMedDRA version: 12.1Level: LLTClassification code 10051604Term: Lung transplant rejectionMedDRA version: 12.1Level: LLTClassification code 10056409Term: Heart and lung transplantMedDRA version: 12.1Level: LLTClassification code 10016547Term: FEVMedDRA version: 12.1Level: LLTClassification code 10016549Term: FEV 1 abnormalMedDRA version: 12.1Level: LLTClassification code 10016550Term: FEV 1 decreasedMedDRA version: 12.1Level: LLTClassification code 10016553Term: FEV 1 lowEUCTR2010-021983-14-BEZ Gasthuisberg30
进行中（未招募）
不适用
A randomized placebo-controlled double blind study to prevent BOS - VIT001A study to prevent the occurence of chronic rejection after lung transplantation. Other points of investigation include lung function evolution, rate of survival, BAL cellularity, infection rate, rate of acute rejection and refluxMedDRA version: 12.1Level: LLTClassification code 10029888Term: Obliterative bronchiolitisMedDRA version: 12.1Level: LLTClassification code 10049202Term: Bronchiolitis obliteransMedDRA version: 12.1Level: LLTClassification code 10068805Term: Follicular bronchiolitisMedDRA version: 12.1Level: LLTClassification code 10019319Term: Heart-lung transplant rejectionMedDRA version: 12.1Level: LLTClassification code 10025127Term: Lung transplantMedDRA version: 12.1Level: LLTClassification code 10050433Term: Prophylaxis against lung transplant rejectionMedDRA version: 12.1Level: LLTClassification code 10050437Term: Prophylaxis against heart and lung transplant rejectionMedDRA version: 12.1Level: LLTClassification code 10051604Term: Lung transplant rejectionMedDRA version: 12.1Level: LLTClassification code 10056409Term: Heart and lung transplantMedDRA version: 12.1Level: LLTClassification code 10016547Term: FEVMedDRA version: 12.1Level: LLTClassification code 10016549Term: FEV 1 abnormalMedDRA version: 12.1Level: LLTClassification code 10016550Term: FEV 1 decreasedMedDRA version: 12.1Level: LLTClassification code 10016553Term: FEV 1 lowEUCTR2010-022027-30-BEZ Gasthuisberg